This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This article is copyrighted strictly for Electronic Health Reporter. Scaling up is a crucial step in the development of biotechnology processes, particularly in upstream biotech development. Illegal copying is prohibited.
This article is copyrighted strictly for Electronic Health Reporter. UC Riverside’s Wet Lab Incubator has opened its doors to biotech entrepreneurs throughout the Inland Empire. The article UC Riverside’s Wet Lab Incubator Open To Biotech Entrepreneurs appeared first on electronichealthreporter.com.
The following is a guest article by Dave Werry , Co-Founder & President at Well Personalized healthcare continues to become more ubiquitous, and its well-documented benefits include greater health outcomes, enhanced convenience, and reduced employer costs. billion by 2033.
Flash back to my article for the Society for Participatory Medicine last year: Let’s Save the Date and Make Patient Engagement Official in 2022. After all of this time and energy expended, it’s only right that patients would be witness to accountability of pharma/biotech to incorporate our collective voice.
This article ran last week in STAT News – delighted to pass it along to my fellow space buffs and thank you to STAT for telling the story of TRISH. By Asha Collins, Lisa Suennen and Armen R. Kherlopian SpaceX Inspiration4, funded by billionaire Jared Isaacman, recently orbited the Earth for three days with an […].
The following is a guest article by Steve Lazer, Global Healthcare & Life Sciences CTO at Dell Technologies. The primary use cases for cognitive AI in biotech include accelerating data analysis, automating document management, improving collaboration, and reducing risk of human error.
You can read more details about this evolving situation in the WSJ article linked above, and other takes in tech, business, and social media that have begun to populate the interwebs. health care. Was this due to the growing experience and reporting of surprise medical bills?
A ccording to a Fierce Biotech Research article, researchers have discovered an area of the brain that is in charge of communicating with the rest of the body about hypoglycemia. Quick Hit. Like many scientific discoveries, this one came as a bit of a surprise.
QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners. According to a recent Deloitte article , ROI on pharma R&D has steadily declined, reaching 1.2
The following is a guest article by Steve Lazer, Global Healthcare & Life Sciences CTO at Dell Technologies. Dell Technologies has developed a suite of digital twin solutions that are specifically designed to accelerate the biotech development process at every stage with patient digital twins.
He co-wrote the first “It’s The Prices Stupid” research article in Health Affairs with Gerard Anderson et. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.
According to a Fierce Biotech IT article, Apple is using an open-source framework called ResearchKit to allow apps to collect medical data from mobile phones.The Apple-made framework takes data from the iPhone’s accelerometer, microphone, and GPS sensor, among other tools, to generate medical data that researchers can use.
The following is a guest article by Dr. Neecey Hudson, PhD – Founder & Chief Scientist at Hood Medicine Initiative. Pandemic preparedness has now become a paramount concern across the globe.
In April, Novo Nordisk announced it has successfully resubmitted Tresiba, a long-acting insulin, to the FDA for approval, according to a Fierce Pharma article. According to a Fierce Biotech report on Tresiba, Novo’s resubmission of Tresiba could backfire for a couple of reasons, say analysts.
The Connected Health Conference also promises an emphasis on the Life Sciences/BioTech and Digital Health, with sessions like the Fireside Chat on Pharma and Digital Health and Transforming the Life Sciences through Digital Health. Can't meet you there? No problem! Carrie Nixon. Carrie Nixon, Esq.
This article is copyrighted strictly for Electronic Health Reporter. The article Inanovate Inc. Illegal copying is prohibited. Inanovate, Inc., a life science company specializing in the development of blood tests for cancer and autoimmune diseases, has secured an initial closing of $3.1million on a Series C financing round.
Dr. Claresa Levetan has written many articles for Insulin Nation how a two-pronged therapy of beta cell regeneration and immunosuppressive drug therapy might achieve insulin independence for people with Type 1 diabetes. Insulin independence trials. Now she gets an important chance to prove it. Wound care with white blood cells.
According to a Fierce Biotech report , Novo Nordisk announced in an October 31st earnings call that it is halting research and development efforts aimed at creating an oral form of insulin. Thanks for reading this Insulin Nation article. Now, there’s evidence that the former may have killed off the latter. Trick or treat!
This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Collaborations between AI vendors and biotech/pharma companies over the last five years are worth more than $45 billion , according to a recent report from Accenture.
This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. The silver lining: Healthcare is the leading sector, though most funds are going to biotech. Welcome to the weekly edition of Healthcare IT Today Bonus Features.
Scientists found in a head-to-head trial of the two insulins, Sanofi’s new formulation led to improved glucose control and fewer bouts of hypoglycemia , according to an article in Medscape Multispecialty. In a multinational trial, Sanofi’s new long-acting insulin outperformed its current long-acting insulin.
The therapy, which holds the promise of generating insulin-producing beta cells for people with Type 1 diabetes, has come under scrutiny again, according to a Fierce BioTech Research report. According to an article in Glu , 5.3% What is it about stem cell studies that make them so prone to their validity being questioned? DKA rate.
I ought to have remembered how the startup game goes … raise my head after a few crunch cycles and I’ve got a lot less hair and every article on CNN is about some angry old guy tweeting stuff. Geekwire) Microsoft partners with Adaptive Biotech on AI-driven blood test to diagnose dozens of diseases at once.
Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. Biotech software vendor Seqera acquired tinybio , maker of a ChatGPT tool for medical researchers. Welcome to our Healthcare IT Today Weekly Roundup. TEFCA’s Role in Facilitating Seamless Data Sharing.
This article will be a roundup of interesting stories, product announcements, partnerships, research studies, company launches, and more from the annual conference. RedHealthy Communications : PR and marketing for biotech, life sciences, and digital health. Welcome to the special HLTH 2023 edition of Healthcare IT Today Bonus Features.
In a recent Fierce Biotecharticle, CEO MacKay warned his staff of “heartbreaking” staff cuts to make the new pricing structure work. However, the impact is already being felt in the industry. Low concedes that major changes will be needed to follow the new CMS standard.
Her dream is that GlobalMed teams up with other medical and biotech companies, doctors and dentists for a bigger impact in underserved communities. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at marketingdept@globalmed.com.
Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally.
According to a Fierce Biotech report , Novo Nordisk announced in an October 31st earnings call that it is halting research and development efforts aimed at creating an oral form of insulin. Thanks for reading this Insulin Nation article. Now, there’s evidence that the former may have killed off the latter. Trick or treat!
This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. The Biotech Breakthrough Awards Program announced its 2022 award winners. Welcome to the weekly edition of Healthcare IT Today Bonus Features.
With the mandate of fostering an ecosystem of applied machine learning startups, Google on Wednesday revealed the first four companies to join its Launchpad Studio and said this initial track is aimed squarely at healthcare and biotech. Article Source: healthcareitnews. Read This: Big data and the future of healthcare .
In an article in Wired magazine in 2017, Ada’s app’s diagnoses outshone those of its competitors, Babylon and YourMD, however. As a result, more and more investors are paying attention to the health sector which, due to its complexity, has traditionally been left to biotech or medical devices investors.
Note in Exhibit 1 from the article the process and outcomes of UM programs for each of the stakeholders. There is one health care public policy issue that unites U.S. voters across political party: that is the consumer-facing costs of prescription drugs. Every one of the processes generates a cost.
Dr. Fendrick was part of a team that wrote one of the first research articles on the effects of increasing patient cost sharing on health disparities — published in 2008 in the Journal of General Internal Medicine. ” Out of the mouths of Mom’s, right?!
The following is a guest article by Bruno Kurtic , Co-Founder, President, and CEO at Bedrock Security It’s becoming increasingly evident that the U.S. The CCP’s national security laws require Chinese firms to share any data requested, which includes the biotech companies that collect, test, and store American genetic data.
The combo drug would combine Novo Nordisk’s long-acting insulin and its insulin-promoting GLP-1 drug into a new product that would be called Xultophy, according to Fierce Biotech. The process also was used to prevent a form of blindness in the whiskered test subjects, according to an article in Fierce Biotech Research.
The New England Journal of Medicine published an essay on June 4, 2020, titled, Specialty Drugs–A Distinctly American Phenomenon (my apologies–the article is behind the NEJM paywall). The phrase “specialty drugs” originated in the 1970s in the advent of injectable and infusion therapies.
The following is a guest article by Dr. Zach Landman, Co-Founder of Moonshots for Unicorns. This same process is now being done at the individual and family basis through a distributed biotech model. Perlara, a San Francisco based, biotechnology company doesn’t have a physical office.
This article is copyrighted strictly for Electronic Health Reporter. The main areas of use of biotechnology today are medicine, pharmaceuticals, agriculture, and other industries, where BioTech innovations can reduce the cost of production, speed up the development of vaccines, or model the changes of […].
Their first project is focused on ViaCyte, a San Diego biotech which is trying to use a novel approach to implant pancreatic progenitor cells into people with diabetes that will mature into functional beta cells. The filmmakers have no affiliation nor financial connection with any of the companies or entities appearing in the film.).
When this occurred, it didn’t cause more than a ripple of interest outside biotech. To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. But the U.S. citizens’ personal data.
He could very well be putting biotech companies on notice that they may, too, find themselves in the crosshairs of his Twitter account, or at least that they should remember who will be in charge come January 20th, 2017. Thanks for reading this Insulin Nation article. This might be what he’s doing with drug companies, as well.
Yesterday’s Wall Street Journal featured an article on A $2 Million Therapy About to Hit [the] Market , discussing a new gene therapy treatment that addresses spinal muscular atrophy (SMA).
Beth writes that, “a whopping two-thirds of Americans now offer a thumbs-up on pharma” as the title of her article, calling out the 30-point gain from 32% in January 2020 to 62% in February 2021. consumers trusted the biotech health industry segment compared with the pharmaceutical segment. Why was this the case?
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content